Company Filing History:
6 out of 917 
6 out of 1,765 
Years Active: 2014-2018
Title: Carlee Erin Ashley: Innovator in Cancer Treatment Technologies
Introduction
Carlee Erin Ashley is a prominent inventor based in Albuquerque, NM, known for his significant contributions to cancer treatment technologies. With a total of six patents to his name, Ashley has focused on developing innovative solutions for targeted drug delivery systems.
Latest Patents
One of Ashley's latest patents is titled "Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same." This invention is designed for the specific targeting of hepatocellular and other cancer cells. It comprises a nanoporous silica core with a supported lipid bilayer, along with agents that facilitate cancer cell death. These agents may include traditional small molecules, macromolecular cargo such as siRNA, or protein toxins. The protocells are engineered to enhance the delivery of therapeutic agents directly to cancer cells, particularly hepatocellular tissue, using novel binding peptides.
Career Highlights
Throughout his career, Carlee Erin Ashley has worked with notable organizations, including Stc.unm and Sandia Corporation. His work has focused on advancing the field of cancer treatment through innovative research and development.
Collaborations
Ashley has collaborated with esteemed colleagues such as Eric C Carnes and C Jeffrey Brinker, contributing to the advancement of cancer treatment technologies.
Conclusion
Carlee Erin Ashley's innovative work in developing protocells for targeted cancer therapy showcases his commitment to improving treatment options for patients. His contributions to the field are paving the way for more effective cancer treatments and drug delivery systems.